<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<STUDY_SET>
    <STUDY alias="DRP010024" center_name="JA_CANCER" accession="DRP010024">
        <IDENTIFIERS>
            <PRIMARY_ID label="BioProject ID">PRJDB11698</PRIMARY_ID>
        </IDENTIFIERS>
        <DESCRIPTOR>
            <STUDY_TITLE>Epigenetic regulation of innate immune signaling following anti-folate treatment(5mC ChIP)</STUDY_TITLE>
            <STUDY_TYPE existing_study_type="Other"/>
            <STUDY_ABSTRACT>To examine whether the treatment of antifolate affect the expression of innate immune signaling through epigenetic mechanisms, we analyzed DNA methylation in NCI-H2122 cells treated with 500nM pemetrexed for 72 hours.</STUDY_ABSTRACT>
            <CENTER_PROJECT_NAME>Epigenetic regulation of innate immune signaling following anti-folate treatment(5mC ChIP)</CENTER_PROJECT_NAME>
            <RELATED_STUDIES>
                <RELATED_STUDY>
                    <RELATED_LINK>
                        <DB>bioproject</DB>
                        <ID>PRJDB11698</ID>
                        <LABEL>PRJDB11698</LABEL>
                    </RELATED_LINK>
                    <IS_PRIMARY>true</IS_PRIMARY>
                </RELATED_STUDY>
            </RELATED_STUDIES>
            <STUDY_DESCRIPTION>To examine whether the treatment of antifolate affect the expression of innate immune signaling through epigenetic mechanisms, we analyzed DNA methylation in NCI-H2122 cells treated with 500nM pemetrexed for 72 hours.</STUDY_DESCRIPTION>
        </DESCRIPTOR>
    </STUDY>
</STUDY_SET>
